Meedoen met studie Home Meedoen met studie 5

6 Years’ experience with HDR Brachytherapy in bladder implantations

Titel 6 Years’ Experience With HDR Brachytherapy In Bladder Implantations Performed Laparoscopically In Solitary Bladder Tumors. A Prospective Study
Auteurs Elzbieta van der Steen-Banasik, Geert Smits, Bernard Oosterveld, Theo Janssen, Dorien Haverkort, Carl Wijburg, Andries Visser
Aandachtsgebied Brachytherapie, Urologie
Doel In our institution laparoscopic bladder implantations were performed since June 2009. In December 2009 a HDR schedule was introduced, replacing the former PDR schedule. In addition laparoscopy was modernized with the introduction of a robot. Here we report our 6 year experience.
Startdatum 4 februari 2016
Locatie Arnhem
Link naar PubMed

Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints

Titel Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
Auteurs Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M.
Aandachtsgebied Brachytherapy, Urologie
Samenvatting Salvage Iodine-125 brachytherapy (I-125-BT) constitutes a curative treatment approach for patients with organ-confined recurrent prostate cancer after primary radiotherapy. Currently, focal salvage (FS) instead of whole-gland or total salvage (TS) is being investigated, to reduce severe toxicity associated with cumulative radiation dose. Differences in urethral and bladder dosimetry and constraints to reduce late (> 90 days) genitourinary (GU) toxicity are presented here.
Datum september 2015
Locatie Radiother Oncol. 2015 Nov;117(2):262-9. doi: 10.1016/j.radonc.2015.08.018. Epub 2015 Sep 5.
  Link naar PubMed

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer

Titel Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
Auteurs Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, Collette L, Fourquet A, Maingon P, Valli M, De Winter K, Marnitz S, Barillot I, Scandolaro L, Vonk E, Rodenhuis C, Marsiglia H, Weidner N, van Tienhoven G, Glanzmann C, Kuten A, Arriagada R, Bartelink H, Van den Bogaert W; EORTC Radiation Oncology and Breast Cancer Groups.
Aandachtsgebied Mamma
Samenvatting The effect of internal mammary and medial supraclavicular lymph-node irradiation (regional nodal irradiation) added to whole-breast or thoracic-wall irradiation after surgery on survival among women with early-stage breast cancer is unknown.
Datum juli 2015
Locatie N Engl J Med 2015;373:317-27. DOI: 10.1056/NEJMoa1415369
   Link naar PubMed

Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.

Titel Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
Auteurs van den Bosch T, Vaarwater J, Verdijk R, Muller K, Kiliç E, Paridaens D, de Klein A, Naus N
Aandachtsgebied Dermatologie
Samenvatting To evaluate risk factors for secondary enucleation after fractionated stereotactic radiotherapy (fSRT) in uveal melanoma.
Datum april 2015
Locatie Acta Ophthalmologica – ACTA-13-12-1139.R2
Link PubMed Abstract

START TYPING AND PRESS ENTER TO SEARCH